Company Overview

Acrongenomics Inc. (OTCBB: AGNM), is a publicly traded company, specializing in the field of Molecular Diagnostics by integrating nanotechnology with molecular biology, the so called Nano-JETA platform. Companys latest achievements include the completion of its unique and unsurpassed Neo-EpCAM Cancer detection kit which overcomes all known problems arising from conventional PCR, ELISA and Real Time PCR. The unparalleled technology used has been proven via extended validated studies in HER1, HER2, HER3, HER4, p53, vEGF as well as HPV, EBV, and HBV.

Acrongenomics technology exhibits the following key features:

Absence of buffer or buffer systems No need for calibration Optional use of MgCl2 Results can be achieved up to ten times quicker compared to all other PCR, and Real Time PCR kits currently available to the market. Substantial reduction in reagent amount needed to perform PCR and Real Time PCR tests. Absence of contamination Compatible to all known conventional PCR and Real Time PCR equipment. Ease of use - no expertise personnel is required to perform the tests. Lack of competition

Company Information

Additional Details

Legal Name: Acrongenomics Inc.

Contacts

Products

• Ep-cam Detection Kit

NAICS Categories

• 334512 Measuring, Medical and Controlling Devices Manufacturing
• 541710 Research and Development in the Physical, Engineering and Life Sciences

Additional Information